Antibacterial Agents TRIZ Cases

Mutant adeno-associated virus capsids alter binding properties to evade serum antibodies, enabling targeted gene delivery to non-permissive cells.

Specific heterocyclic compounds block the PD-1/PD-L1 pathway, overcoming cancer immune evasion and restoring effective T-cell activity.

Modified sphingoglycolipid analogues use O→N acyl-migration to improve solubility while resolving T-cell anergy and mixed cytokine responses.

Specific capture-binder isolates full-length DPP3, resolving non-specific inhibition interference during aminopeptidase analysis.

A topical anti-microbial composition uses quaternized chitosan derivatives combined with amphoteric surfactants to target skin infections.

Structure-based design creates compounds that bind ribosomes, overcoming resistant bacterial strains.

Klebsiella oxytoca strains outcompete pathogens for beta-glucosidic sugars to reduce gut colonization.

Crystalline PLK inhibitor salts resolve poor water solubility and hygroscopicity of the free base, enabling stable oral formulation.

Self-assembling guanidinium polycarbonates kill multidrug-resistant Klebsiella pneumoniae while sparing mammalian cells from toxicity.

Targeted substitutions at specific residues reduce deamidation, improving stability and purity for ex-vivo manufacturing.

Combines monobactam derivatives with beta-lactamase inhibitors to counteract bacterial resistance mechanisms and restore antibiotic reliability.

Formula I adjuvants reverse resistance in gram-negative bacteria by modifying outer membrane charge, restoring cationic antimicrobial peptide efficacy.

Antibodies bind ZNRF3 or RNF43 extracellular domains to increase Wnt signaling activity for treating low signaling disorders.

Lyophilized nanoparticle compositions form immunogenic suspensions under 250 nm, resolving antigen loading and aseptic processing bottlenecks.

Novel 2-pyridone compounds inhibit type II topoisomerases to disrupt bacterial DNA replication.

Replacing fluoride with theobromine and calcium phosphate prevents caries while increasing mechanical strength without toxicity.

Pyrazole derivatives modulate PARP activity to prevent excessive NAD and ATP consumption during DNA repair.

Transgenic vectors with humanized immunoglobulin loci generate high-titer antibodies while minimizing immunogenicity in humans.

PglL enzyme co-expression replaces random chemical cross-linking, ensuring uniform conjugate homogeneity and high purity.

Yeast vaccine vectors overcome glycosylation limits by expressing large antigenic proteins with immunostimulatory polypeptides for lasting immunity.

Novel substituted piperidyl-propane-thiols modulate chemokine receptor CCR-3 activity through specific structural substitution patterns.

Zinc and copper gluconate dietary supplements enhance mineral absorption, reducing zinc excretion and methicillin-resistant Staphylococcus aureus infestations.

Merges antibacterial and antifungal agents in one formulation to prevent recurrence of foot infections in high-risk patients.

Neutralizing monoclonal antibodies bind specific protective antigen epitopes to block anthrax toxins, resolving vaccine reactogenicity.

Oxazolidinone derivatives degrade extracellular DNA to disperse biofilms, restoring antibiotic efficacy against resistant pathogens.

Poloxamer 407 gels bypass the blood-labyrinth barrier to deliver active agents while maintaining ionic balance and preventing osmotic imbalance.

Segmented antibody formats target BCMA-expressing cells, resolving therapy specificity trade-offs.

Core-shell nanofibers release antibacterial agents via a bacterially degradable polymer shell, reducing cytotoxicity and preventing wound infections.

Surface functionalization with PEG and cyclodextrins enables modified MOF nanocarriers to evade immune elimination and prevent liver accumulation.

A bispecific molecule binds TIGIT and VEGF to block signaling pathways.

A supercritical CO2 extraction process isolates prenylated flavonoids from Glycyrrhiza sp. roots.

A cationic fraction extracted from milk treats bovine mastitis using synergistic antimicrobial components.

Specific crystal lattice structures stabilize tiacumicin B, reducing economic burden from treatment failures while maintaining consistent bioavailability.

Retinoic acid in oil-in-water emulsions induces mucosal homing of T cells without complex delivery systems.

Alkaline pH enables mild amino acid surfactants to achieve effective antibacterial activity without compromising skin gentleness.

Ginseng-derived nanoparticles induce monocyte-macrophage proliferation and activation.

Diphtheria toxoid carrier proteins enable meningococcal conjugate vaccines to function effectively in pre-immunized patients.

Lactose stabilizes tigecycline in a dry powder matrix while pH adjustment during drying ensures drug integrity for pulmonary treatment.

Disulfide linkers resolve maleimide instability by ensuring homogeneous drug-to-antibody ratios.

Engineered phasmids deliver CRISPR RNAs to kill target pathogens while preserving the gastrointestinal microbiota composition.

Glycerophosphoinositols mitigate septic shock severity by inhibiting LPS-induced tissue factor activity and regulating inflammatory gene expression.

Conjugating type III capsular polysaccharides to the AlpC carrier protein overcomes limited serotype coverage in traditional vaccines.

Bioactive glass releases metal ions to inhibit biofilms, reducing infection risk and accelerating wound healing.

Naphthoquinone inhibitors target methionine aminopeptidases to overcome multi-drug resistant Mycobacterium tuberculosis strains.

Vib-PAP-1 phage composition eliminates pathogenic bacteria without harming normal microflora, preventing antibiotic resistance in aquaculture.

Switching from ethanolic to water/organic solvent mixtures resolves crystalline form issues, enhancing solubility and bioavailability for pulmonary treatments.